arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

IRONWOOD PHARMACEUTICALS INC

IRWD
$4.33 ▲ +0.07 (+1.53%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
65
Health
Fair
Bullish
auto_awesome

Analytical Summary

IRONWOOD PHARMACEUTICALS INC shows strong fundamentals with top-quartile Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $707.7M
Dividend Yield
Revenue Growth 158.9%
Op. Margin 68.1%
ROIC -20.9%
FCF / Share $0.03
Trailing P/E 17.3x
Price / Book
FCF Yield 0.7%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$106.51M
↑ +158.9%
Net Income Profit after all expenses
$40.77M
↑ +1891.4%
Operating Margin Operating profit as % of sales
68.1%
↑ +377.7% 89th
FCF / Share Free cash flow per share
$0.03
↓ -74.7%
Long-Term Debt Long-term obligations
$199.51M
— +0.1%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
82
Returns
35
Financial Health
66
Cash Quality
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters